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Abstract 
An acid dissociation constant (pKa) of bupropion has been determined in an aqueous solution by capillary zone electrophoresis 
(CZE).  Electrophoretic mobility of bupropion was measured by CZE over its acid-dissociating pH range, and a pKa value has 
been determined as 8.75±0.02 (mean ± standard error, ionic strength: 0.010 mol dm−3).  Although bupropion degrades under 
heated and alkaline conditions and the degraded species from bupropion coexist in the aqueous solution, the pKa value of 
bupropion can also be determined by CZE with the residual bupropion without any interference from the degraded species. 
The pKa value determined after the heat-degradation was 8.74±0.02; the result agreed well with the one determined with the 
freshly prepared solution.  Utilization of the separation characteristics of CZE has been demonstrated with bupropion for the 
analysis of the fast equilibrium of acid-base reaction under the coexistence of the degraded species.   
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1. Introduction
Capillary zone electrophoresis (CZE) is a useful tool to
determine the acid dissociation constant (pKa) of 
pharmaceuticals in an aqueous solution [1,2].  Protonation 
or deprotonation of any acid-base substances accompanies 
with the changes in its effective charge with varying pH of 
the solution, which results in the change in the effective 
electrophoretic mobility of the substance.  The effective 
electrophoretic mobility was used for the determination of 
the acid dissociation constant of the substances of interest. 
Advantages on using CZE for the pKa determination 
include: (1) aqueous solution is handled in CZE without any 
stationary matrix, (2) low concentration of an analyte is 
acceptable if detected, (3) small sample volume is available, 
and (4) other substances except the analyte are allowed to 
coexist owing to the CZE separation [1,2].  Dissociation 
constant of ropinirole has been determined by CZE in the 
presence of some impurities [3].   
The CZE separation is also beneficial to the analysis of 
labile substances; degraded species from the labile 
substance as an analyte can be resolved from the analyte, 
and thus the equilibrium is analyzed with the labile analyte 
by measuring the effective electrophoretic mobility [4,5]. 
Phenolphthalein is known to be degradable at alkaline 
aqueous solution.  Although the acid-base property of 
phenolphthalein was difficult to analyze by photometric 
titration in an aqueous solution [6], the pKa values were 
determined by CZE even under the degrading conditions by 
resolving the kinetically degrading species from the 
equilibrium species of phenolphthalein [4].  Applicability 
of the CZE analysis has been demonstrated with the labile 
substances with a series of pharmaceutical candidates [5]. 
Acid dissociation constants of degradable pharmaceuticals 
of haloperidol [7] and pravastatin [8] have been analyzed by 
CZE under the coexistence of their degradation products.   
Bupropion hydrochloride (Fig. 1, base form) is an 
antidepressant of aminoketone class (Wellbutrin, 
GlaxoSmithKline) with neurochemical properties different 
from those of common tricyclic antidepressants and 
monoamine oxidase inhibitors [9,10].  It works as a 
dopamine and norepinephrine reuptake inhibitor [11].  It is 
also licensed to non-nicotine pharmacological therapy for 
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smoking cessation (Zyban, GlaxoSmithKline) [12].  
Metabolism in human plasma [13] and degradation under 
stressed conditions [14] have been investigated with BUP.  
It is reported that 3-chlorobenzoic acid and some alcohols 
are formed by the degradation of bupropion under heated 
and alkaline conditions [14].  Capillary zone 
electrophoresis has been used for the chiral resolution of 
BUP by electrokinetic chromatography by using 
sulfated--cyclodextrin as a chiral selector [15].   
In this study, utilization of the CZE determination of pKa 
has been demonstrated with the degradable bupropion in an 
aqueous solution even after the degradation under heat.  
An acid dissociation constant of BUP has been determined 
with both freshly-prepared and heat-degraded BUP.   
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Fig. 1.  Structure of bupropion (BUP).   
 
2. Experimental 
2.1. Apparatus 
An Agilent Technologies 3DCE was used as a capillary 
electrophoresis system, equipped with a photodiode array 
detector.  A fused-silica capillary purchased from GL 
Sciences (Tokyo, Japan) was held in a capillary cassette and 
the cassette was installed in the CE system; the capillary 
cassette was thermostat at 25oC.  The dimensions of the 
capillary were 64.5 cm in total length, 56 cm in effective 
length from the injection point to the detection point, and 50 
m in inner diameter.  An Agilent Technologies 
ChemStation software (Ver. B.04.02) was used to control 
the 3DCE system and to record and analyze the 
electropherograms.   
A Waters LCT Premire XE was used as an LC-MS 
system.  A reversed-phase column of Acquity UPLC BEH 
C18 (50 mm in length × 2.1 mm in inner diameter, particle 
size: 1.7 m) was attached to the LC-MS system.  A 
mixed solvent of 50%(v/v) methanol in water was used as 
an eluent.  A TOA DKK HM-25G pH meter equipped 
with a combined glass electrode was used for the pH 
measurements of the separation buffers after calibrated 
daily with the standard solutions.  A Nitride 
Semiconductors (Naruto, Tokushima) NS 375 LIM was 
used as a UV lamp.   
 
2.2. Chemicals 
Bupropion hydrochloride was purchased from Tokyo 
Chemical Industry (Tokyo, Japan).  It was dissolved in 
purified water at a concentration of 1.0×10−3 mol dm−3; it 
was used after dilution with water.  1-Ethylquinolinium 
iodide (EtQu+I−) and 3-chlorobenzoic acid were also from 
Tokyo Chemical Industry.  Other reagents were of 
analytical grade.  Water used was purified by Milli-Q 
gradient A10 (Merck-Millipore, Darmstadt, Germany).   
Separation buffers were prepared with 0.010 mol dm−3 
MES-NaOH (pH 5.5−6.9), 0.010 mol dm−3 HEPES-NaOH 
(pH 7.1−8.4), or 0.010 mol dm−3 H3BO3-NaOH (pH 
8.5−9.3).  Ionic strength of the buffers was controlled at 
0.010 mol dm−3 by adding appropriate amount of NaCl.   
 
2.3. Procedure for the determination of pKa by CZE 
After the separation capillary was filled with a separation 
buffer and equilibrated, a sample solution containing 
bupropion hydrochloride at 2.0×10−5 mol dm−3 and 
1-ethylquinolinium iodide at 2.0×10−5 mol dm−3 was 
introduced into the capillary by applying pressure (250 
mbar s).  Ethanol was also added in the sample solution at 
the concentration of 1.0%(v/v) to monitor the 
electroosmotic flow (EOF).  Then, a separation voltage of 
25 kV was applied to the capillary for the zone 
electrophoresis.  An analyte of BUP was photometrically 
detected at 220 nm.  Effective electrophoretic mobility of 
BUP, eff,Bup, was calculated in an ordinary manner with the 
migration times of BUP and EOF, and an acid dissociation 
constant of BUP was determined by a non-linear 
least-squares analysis with a series of the eff,Bup values after 
standardized with the electrophoretic mobility of EtQu+.  
A software of R program (Ver. 3.1.1) was used for the 
analysis [16].   
 
3. Results and discussions 
3.1. Determination of an acid dissociation constant of BUP 
by CZE 
Bupropion with its protonated form, HBup+, dissociates a 
proton to form a neutral Bup in an aqueous solution as in 
equilibrium (1) with its acid dissociation constant, Ka.  The 
acid dissociation constant is written as in Eq. (2).   
 
HBup+       Bup  +  H+      (1) 
 
   [H+] [Bup] 
Ka =                (2)    [HBup+] 
 
The acid-base equilibrium is sufficiently fast against the 
separation time of CZE.  Thus the effective electrophoretic 
mobility of BUP, eff,Bup, is contributed from the two species 
of HBup+ and Bup, and it is written as in Eq. (3).   
 
      [H+]         Ka eff,Bup =       ep,HBup +       ep,Bup   (3)      [H+] + Ka      [H+] + Ka 
where ep,HBup and ep,Bup are the electrophoretic mobility of 
HBup+ and Bup species, respectively.  Since Bup is neutral, 
a value of ep,Bup in Eq. (3) was set as zero in the analysis.  
A series of pairs of [H+] and eff,BUP were input in Eq. (3) 
and values of Ka and ep,HBup were optimized by a non-linear 
least-squares analysis [17].   
In this study, the acid dissociation constant of HBup+ has 
firstly been determined through the electrophoretic mobility 
of BUP over its dissociable pH range.  Typical 
electropherograms are shown in Fig. 2.  The migration 
time of BUP is shorter than that of EOF at the weakly acidic 
to neutral pH region, which suggests the cationic BUP in an 
aqueous solution.  It is getting closer to that of EOF with 
increasing pH of the separation buffer.  The result is 
interpreted as the acid dissociation equilibrium of HBup+, 
as written in Eq. (1).  Changes in the effective 
electrophoretic mobility of BUP are shown in Fig. 3.  The 
value of eff,Bup was standardized with that of EtQu+, EtQu, 
since EtQu+ is a monocation over the pH range and the 
electrophoretic mobility of EtQu+ is thus a certain value.  
The standardized value, eff,Bup/EtQu, was used for the 
analysis of the Ka  value.  As is noticed in the 
electropherograms in Fig. 2, it can also be noticed in Fig. 3 
that the positive electrophoretic mobility has been observed 
with BUP at the weakly acidic pH region.  The 
eff,Bup/EtQu value decreases with increasing pH of the 
separation buffer by the deprotonation from HBup+.  An 
acid dissociation constant of pKa = 8.75±0.02 (mean ± 
standard error) was determined by the analysis.  A curve in  
 
  
Fig. 2.  Electropherograms of bupropion with changing pH 
of the separation buffer.  Signals: ○, BUP; ▲, EtQu+.  S, 
EOF.  pH of the separation buffers: (a), 6.22; (b), 7.08; (c), 
8.50; (d), 9.60.  The CZE conditions are written in the text.   
 
 
Fig. 3.  Changes in the effective electrophoretic mobility 
of BUP with pH.  ○, Freshly prepared BUP; ▲, degraded 
BUP under 70oC for 7 days.  The CZE conditions and the 
degradation conditions are written in the text.   
 
Fig. 3 is the simulated result with the optimized pKa and 
eff,Bup/EtQu values.  The pKa value determined in this 
study is somewhat different from the reported values; 7.0 
[18,19], 7.2 [20], 7.4 [21] and 7.9 [9,10].  It is not certain 
if the reported values could have excluded the interferences 
from the degraded species.  In CZE, the electrophoretic 
mobility is measured in an aqueous solution without any 
interference from the coexisting substances including the 
degraded species and a drastic change in electrophoretic 
mobility accompanies with the acid dissociation 
equilibrium, the pKa value determined in this study would 
be a reliable one compared with the reported values.   
 
3.2. Degradation of BUP 
It has been reported that BUP is degradable under several 
conditions [14].  In this study, five stressed conditions of 
acidic (0.010 mol dm−3 HCl), alkaline (0.010 mol dm−3 
NaOH), UV light radiation (375 nm, 1.4 W; the bupropion 
solution in a glass vial was irradiated with the light on the 
top of the window of the lamp housing), heat (70oC), and 
oxidative (1.0%(v/v) H2O2) were examined.  An aliquot of 
1.0×10−3 mol dm−3 aqueous BUP solution was exposed to 
one of the stressed conditions, and a small portion of it was 
periodically sampled over several days and analyzed by 
CZE after 10 times dilution with the purified water.   
The residual amount of BUP was quantified by CZE, 
where the peak height of BUP was standardized with that of 
5.0×10−4 mol dm−3 EtQu+ for the quantification.  The 
results are shown in Fig. 4; bupropion gradually 
decomposed under heated or alkaline conditions as 
previously reported [14].  The residual amount of BUP 
was about 50% under heated for 8 days and about 10% 
under alkaline for 7 days.   
The degraded solution of BUP heated at 70oC for 11 days 
was analyzed by the LC-MS to examine the degradation 
products.  After the degraded solution was diluted 100 
times, an aliquot of 20 L of the solution was introduced 
into the LC-MS.  Negative masses of 154.99 and 156.99 
with a retention time at 0.74 min were detected.  Both of 
the masses correspond to 3-chlorobenzoate ion (3-ClBz−, 
Fig. 5, 2), and it is supposed to be formed from BUP, as has 
been reported [14].  Positive masses of 184.05 and 186.05 
with a retention time at 0.94 min were also detected by the 
LC-MS.  They would be 
1-(3-chlorophenyl)-2-hydroxy-1-propanone (Fig. 5, 3), as 
was also reported [14].   
 
  
Fig. 4.  Degradation profile of BUP under some stressed 
conditions.  Residual BUP was quantified by CZE, where 
5.0×10−4 mol dm−3 EtQu+ was used as a quantification 
standard with the peak height.  Degradation conditions: ○, 
heated at 70oC; ●, alkaline with 0.010 mol dm−3 NaOH; ▲, 
acidic with 0.010 mol dm−3 HCl; □, UV light irradiation; ■, 
oxidative with 1.0%(v/v) H2O2.  
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Fig. 5.  Degraded species from bupropion reported [14].  
The two species were also detected in this study by LC-MS.   
The degraded species from BUP was verified by CZE; 
the results are shown in Fig. 6.  A CZE signal 
corresponding to an anionic species is detected at 5.9 min 
with the degraded solution.  When 3-chlorobenzoate is 
spiked to the degraded solution, the CZE signal at 5.9 min 
increased.  Therefore, the degraded species is also verified 
as 3-ClBz−.  However, a degraded species of 3 was not 
detected by CZE, because it is neutral.   
 
 Fig. 6.  Electrophorerograms of degraded BUP for the 
qualitative analysis of the degradation product.  Separation 
buffer, H3BO3-NaOH (pH 8.49).  Detection wavelength, 
200 nm.  Signals: ○, BUP; ▲, EtQu+; ■, a degradation 
product (3-ClBz−). S, EOF.  Other conditions are written in 
the text.  (a) degraded BUP under 70oC for 8 days spiked 
with 1.0×10−4 mol dm−3 3-chlorobenzoic acid; (b) degraded 
BUP under 70oC for 8 days.  The degraded solution was 
diluted by 10 times and measured.   
 
3.3. Determination of an acid dissociation constant of BUP 
after heat-degradation 
It is noticed in Fig. 6 that the residual BUP is still 
detected with the degraded BUP solution.  The residual 
bupropion is resolved from the degraded species.  
Therefore, the acid dissociation equilibrium of BUP can be 
analyzed with the residual BUP by CZE through the 
measurements of its electrophoretic mobility, even in the 
presence of the degraded species.   
The acid dissociation constant of BUP was also 
determined with the degraded BUP solutions heated at 70oC 
for 7 days.  Since CZE includes electrophoretic separation, 
the degraded species would be resolved from BUP and they 
would not interfere with the BUP signal.  Typical 
electropherograms are shown in Fig. 7.  Difference in the 
electropherograms between freshly-prepared (Fig. 2) and 
heat-degraded (Fig. 7) solutions is that the relative signal 
height of BUP against a standard of EtQu+ is smaller with 
the degraded solution.  However, the CZE signals 
corresponding to BUP is still detected with the degraded 
solution.  Signals corresponding to the degradation 
product of 3-ClBz− are also detected in Fig. 7.  Effective 
electrophoretic mobility of BUP was also plotted as a 
function of pH; the results are also shown in Fig. 3.  
Analysis of the changes in the effective electrophoretic 
mobility gave a pKa value of 8.74±0.02.  The pKa value 
determined with the degraded solution is almost identical to 
the one determined with the freshly prepared solution.   
 
  
Fig. 7.  Electrophorerograms of the degraded BUP with 
changing pH of the separation buffer.  The degradation 
conditions are written in the text.  pH of the separation 
buffer: (a), 6.25; (b), 7.10; (c), 8.49; (d), 9.28.  ○, BUP; ▲, 
EtQu+; ■, 3-ClBz− as a degradation product from BUP.   
 
4. Conclusions 
In this study, an acid dissociation constant of bupropion 
has been determined after the heat-degradation.  Even 
though BUP is degraded by heat, the acid dissociation 
constant was successfully determined with the residual BUP 
without any interference from the degraded species.  It is 
demonstrated in this study that the CZE analysis is useful to 
such acid-base equilibria as including the degradation 
reaction and the degradation products.   
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